Medical Weight Loss for Ruston, Louisiana Residents

Ruston, Louisiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Ruston through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Ruston: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your Louisiana address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Ruston Residents Choose New Hope Weight Loss

What draws a lot of Ruston patients to New Hope is the honest pricing. Semaglutide starts at $166 a month and tirzepatide at $233 a month, with a $119 physician visit, and that is the whole conversation. There is no surprise line item, no distance surcharge for living outside Costa Mesa, and no pressure to buy a bundle you did not ask for. You see the real numbers before you commit, which is how it should be.

Ruston is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Ruston patients at home.

There is no New Hope Weight Loss office in Ruston, and there does not need to be, since the same doctor-led program is delivered to every corner of Louisiana through telehealth visits. We care for patients throughout downtown Ruston, the university area, and the greater Lincoln Parish area. You can have your first video visit from your kitchen in Ruston and have your treatment plan in motion the same week.

By handling visits through telehealth, we serve every neighborhood in Ruston, from downtown Ruston, the university area, and the greater Lincoln Parish area, without asking anyone to travel. Cold-pack shipping to Ruston is handled for you, and refills are coordinated through telehealth so you do not have to manage a pharmacy pickup. From one end of Louisiana to the other, New Hope Weight Loss provides physician-supervised GLP-1 care by telehealth from our Costa Mesa, California clinic, with no need to visit in person.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Ruston patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Ruston

Think of it as four easy moments. You begin with an online intake quiz that asks about your weight, your health history, and what you want to achieve. Dr. Anjmun Sharma then reviews your answers and meets you by secure video, generally within 48 hours, to talk honestly about whether compounded semaglutide or tirzepatide could help you. If she prescribes one, a state-licensed 503(a) pharmacy fills it and ships it to your Ruston address in protective cold-pack packaging. Finally, your follow-up care is delivered by video, so people throughout can stay on plan without ever sitting in a waiting room.

Frequently Asked Questions, Ruston

Where is the New Hope Weight Loss location serving Ruston?

The location serving Ruston is our Costa Mesa, California clinic, which is our only physical site. We care for Ruston, Louisiana patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Ruston patients?

It is the standard for Ruston. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Ruston in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Ruston patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Ruston patients.

What areas of Ruston do you serve?

We serve patients from across Ruston by telehealth, including downtown Ruston, the university area, and the greater Lincoln Parish area.

Is bilingual (Spanish) telehealth care available for Ruston patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Ruston patients.

Ruston Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Ruston, Louisiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.